The clinical spectrum of lymphatic disease

Annals of the New York Academy of Sciences

Volumn 1131, Issue , 2008, Pages 155-184

  Radhakrishnan, Kavita ^a   Rockson, Stanley G ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chromosomal disorders; Lymphangioleiomyomatosis; Lymphangioma; Protein losing enteropathy (PLE)

Indexed keywords

AUTOSOMAL DOMINANT DISORDER; CONFERENCE PAPER; CONGENITAL BLOOD VESSEL MALFORMATION; GENETIC DISORDER; HUMAN; INFECTION; INTESTINE LYMPHANGIECTASIA; LYMPHANGIOLEIOMYOMATOSIS; LYMPHANGIOMA; LYMPHATIC SYSTEM DISEASE; LYMPHEDEMA; MENTAL RETARDATION MALFORMATION SYNDROME; PROTEIN LOSING GASTROENTEROPATHY;

EID: 44449138892     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1413.015     Document Type: Conference Paper

References (120)

1. Ristevski, B., H. Becker, M. Cybulsky, et al. 2006. Lymph, lymphocytes, and lymphatics. Immunol. Res. 35 : 55 64.
2. Harvey, N.L., R.S. Srinivasan, M.E. Dillard, et al. 2005. Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat. Genet. 10 : 1072 1081.
3. Rockson, S.G. 2001. Lymphedema. Am. J. Med. 110 : 288 295.
4. Szuba, A. & S.G. Rockson. 1997. Lymphedema: anatomy, physiology and pathogenesis. Vasc. Med. 2 : 321 326.
5. Rockson, S.G. 2006. Lymphedema. Curr. Treat. Options Cardiovasc. Med. 8 : 129 136.
6. Nonne, M. 1891. Vier Fälle von Elephantiasis congenita hereditaria. Virchows Archiv. 125 : 189 196.
7. Milroy, W. 1892. An undescribed variety of hereditary oedema. N.Y. Med. J. 56 : 505 508.
8. Brice, G., A.H. Child, A. Evans, et al. 2005. Milroy disease and the VEGFR-3 mutation phenotype. J. Med. Genet. 42 : 98 102.
9. Rosbotham, J.L., G.W. Brice, A.H. Child, et al. 2000. Distichiasis-lymphoedema: clinical features, venous function and lymphoscintigraphy. Br. J. Dermatol. 142 : 148 152.
10. Falls, H.F. & E.D. Kertesz. 1964. A new syndrome combining pterygium colli with developmental anomalies of the eyelids and lymphatics of the lower lxtremities. Trans. Am. Ophthalmol. Soc. 62 : 248 275.
11. Irrthum, A., M.J. Karkkainen, K. Devriendt, et al. 2000. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am. J. Hum. Genet. 67 : 295 301.
12. Kriederman, B.M., T.L. Myloyde, M.H. Witte, et al. 2003. FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome. Hum. Mol. Genet. 12 : 1179 1185.
13. Petrova, T.V., T. Karpanen, C. Norrmen, et al. 2004. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 10 : 974 981.
14. Turner, H.H. 1938. Classic pages in obstetrics and gynecology: a syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology 23 : 566 574.
15. Saenger, P. 1996. Turner's syndrome. N. Engl. J. Med. 335 : 1749 1754.
16. Gravholt, C.H., J. Fedder, R.W. Naeraa, et al. 2000. Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population study. J. Clin. Endocrinol. Metab. 85 : 3199 3202.
17. Sybert, V.P. & E. McCauley. 2004. Turner's syndrome. N. Engl. J. Med. 351 : 1227 1238.
18. Saenger, P. 1993. Clinical review 48: the current status of diagnosis and therapeutic intervention in Turner's syndrome. J. Clin. Endocrinol. Metab. 77 : 297 301.
19. Quigley, C.A., B.J. Crowe, D.G. Anglin, et al. 2002. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J. Clin. Endocrinol. Metab. 87 : 2033 2041.
20. Klinefelter, H.F. Jr., E.C. Reifenstein Jr. & F. Albright. 1942. Syndrome characterized by gynecomastia, aspermatogenesis without a-Leydigism and increased excretion of follicle-stimulating hormone. J. Clin. Endocrinol. Metab. 2 : 615 624.
21. Kamischke, A., A. Baumgardt, J. Horst, et al. 2003. Clinical and diagnostic features of patients with suspected Klinefelter syndrome. J. Androl. 24 : 41 48.
22. Mandoki, M.W., G.S. Sumner, R.P. Hoffman, et al. 1991. A review of Klinefelter's syndrome in children and adolescents. J. Am. Acad. Child. Adolesc. Psychiatry 30 : 167 172.
23. Wertelecki, W., J.M. Graham, Jr. & F.R. Sergovich. 1976. The clinical syndrome of triploidy. Obstet. Gynecol. 47 : 69 76.
24. Schwaibold, H., I. Dulisch, C.H. Wittekind, et al. 1990. Triploidy syndrome in a liveborn female. Teratology 42 : 309 315.
25. Sherard, J., C. Bean, B. Bove, et al. 1986. Long survival in a 69,XXY triploid male. Am. J. Med. Genet. 25 : 307 312.
26. Doshi, N., U. Surti & A.E. Szulman. 1983. Morphologic anomalies in triploid liveborn fetuses. Hum. Pathol. 14 : 716 723.
27. Edwards, J.H., D.G. Harnden, A.H. Cameron, et al. 1960. A new trisomic syndrome. Lancet 1 : 787 790.
28. Malik, R., V.K. Pandya, S. Malik, et al. 2006. Holoprosencephaly: a feature of Patau syndrome. Indian J. Radiol. Imaging. 16 : 87 89.
29. Patau, K., D.W. Smith, E. Therman, et al. 1960. Multiple congenital anomaly caused by an extra autosome. Lancet 1 : 790 793.
30. Faul, J.L., G.J. Berry, T.V. Colby, et al. 2000. Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am. J. Respir. Crit. Care Med. 161 : 1037 1046.
31. Mordehai, J., E. Kurzbart, D. Shinhar, et al. 1998. Lymphangioma circumscriptum. Pediatr. Surg. Int. 13 : 208 210.
32. Whimster, I.W. 1976. The pathology of lymphangioma circumscriptum. Br. J. Dermatol. 94 : 473 486.
33. Chervenak, F.A., G. Isaacson, K.J. Blakemore, et al. 1983. Fetal cystic hygroma: cause and natural history. N. Engl. J. Med. 309 : 822 825.
34. Okada, A., A. Kubota, M. Fukuzawa, et al. 1992. Injection of bleomycin as a primary therapy of cystic lymphangioma. J. Pediatr. Surg. 27 : 440 443.
35. Mikhail, M., R. Kennedy, B. Cramer, et al. 1995. Sclerosing of recurrent lymphangioma using OK-432. J. Pediatr. Surg. 30 : 1159 1160.
36. Nutman, T.B. 2001. Lymphatic filariasis: new insights and prospects for control. Curr. Opin. Infect. Dis. 14 : 539 546.
37. Kumaraswami, V. 2000. The clinical manifestations of lymphatic filariasis. In Lymphatic Filariasis. Tropical Medicine: Science and Practice, Vol. 1. T.B. Nutman, Ed. : 103 126. Imperial College Press. London.
38. Shenoy, R.K., A. John, B.S. Babu, et al. 2000. Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations. Ann. Trop. Med. Parasitol. 94 : 607 614.
39. Dunyo, S.K., F.K. Nkrumah & P.E. Simonsen. 2000. A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana. Trans. R. Soc. Trop. Med. Hyg. 94 : 205 211.
40. Hoerauf, A., L. Volkmann, K. Nissen-Paehle, et al. 2000. Targeting of Wolbachia endobacteria in Litomosoides sigmodontis: comparison of tetracyclines with chloramphenicol, macrolides and ciprofloxacin. Trop. Med. Int. Health 5 : 275 279.
41. Ryncarz, R., E.C. Heasley & T.J. Babinchak. 1999. The clinical spectrum of nodular lymphangitis. Hosp. Phys. 35 : 63 66.
42. Craven, R.B. & A.M. Barnes. 1991. Plague and tularemia. Infect. Dis. Clin. North. Am. 5 : 165 175.
43. Kostman, J.R. & M.J. DiNubile. 1993. Nodular lymphangitis: a distinctive but often unrecognized syndrome. Ann. Intern. Med. 118 : 883 888.
44. Johnson, S. 1999. Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms. Thorax 54 : 254 264.
45. Travis, W.D., J. Usuki, K. Horiba, et al. 1999. Histopathologic studies on lymphangioleiomyomatosis. In LAM and Other Diseases Characterized by Smooth Muscle Proliferation. J. Moss, Ed. : 171 217. Marcel Dekker. New York.
46. Kalassian, K.G., R. Doyle, P. Kao, et al. 1997. Lymphangioleiomyomatosis: new insights. Am. J. Respir. Crit. Care. Med. 155 : 1183 1186.
47. Johnson, S.R., C.A. Clelland, J. Ronan, et al. 2002. The TSC-2 product tuberin is expressed in lymphangioleiomyomatosis and angiomyolipoma. Histopathology 40 : 458 463.
48. Ferrans, V.J., Z.X. Yu, W. Nelson, et al. 2000. Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features. J. Nippon. Med. Sch. 67 : 311 329.
49. Chu, S.C., K. Horiba, J. Usuki, et al. 1999. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest. 115 : 1041 1052.
50. Urban, T., R. Lazor, J. Lacronique, et al. 1999. Pulmonary lymphangioleiomyomatosis: a study of 69 patients. Medicine 78 : 321 337.
51. Allen, E.V. & E.A. Hines. 1940. Lipedema of the legs: a syndrome characterized by fat legs and orthostatic edema. Mayo. Clin. Proc. 15: 184-187.
52. Wold, L.E., E.A. Hines, Jr. & E.V. Allen. 1951. Lipedema of the legs; a syndrome characterized by fat legs and edema. Ann. Intern. Med. 34 : 1243 1250.
53. Warren, A.G., B.A. Janz, L.J. Borud, et al. 2007. Evaluation and management of the fat leg syndrome. Plast. Reconstr. Surg. 119 : 9e 15e.
54. Fonkalsrud, E.W. 1977. A syndrome of congenital lymphedema of the upper extremity and associated systemic lymphatic malformations. Surg. Gynecol. Obstet. 145 : 228 234.
55. Bilancini, S., M. Lucchi, S. Tucci, et al. 1995. Functional lymphatic alterations in patients suffering from lipedema. Angiology 46 : 333 339.
56. Rudkin, G.H. & T.A. Miller. 1994. Lipedema: a clinical entity distinct from lymphedema. Plast. Reconstr. Surg. 94 : 841 849.
57. Hennekam, R.C., R.A. Geerdink, B.C. Hamel, et al. 1989. Autosomal recessive intestinal lymphangiectasia and lymphedema, with facial anomalies and mental retardation. Am. J. Med. Genet. 34 : 593 600.
58. Van Balkom, I.D., M. Alders, J. Allanson, et al. 2002. Lymphedema-lymphangiectasia-mental retardation (Hennekam) syndrome: a review. Am. J. Med. Genet. 112 : 412 421.
59. Gabrielli, O., C. Catassi, A. Carlucci, et al. 1991. Intestinal lymphangiectasia, lymphedema, mental retardation, and typical face: confirmation of the Hennekam syndrome. Am. J. Med. Genet. 40 : 244 247.
60. McEntagart, M.E., T. Webb, C. Hardy, et al. 2000. Familial Prader-Willi syndrome: case report and a literature review. Clin. Genet. 58 : 216 223.
61. Prader, A., A. Labhart & H. Willi. 1956. Ein syndrome von adipositas, Kleinwuchs, Kryptorchismus and Oligophreniech myatonieartigen Zustand in neugoborenanalter. Schweiz. Med. Wochenschr. 86 : 1260 1261.
62. Khan, N.L. & N.W. Wood. 1999. Prader-Willi and Angelman syndromes: update on genetic mechanisms and diagnostic complexities. Curr. Opin. Neurol. 12 : 149 154.
63. Bull, L.N., E. Roche, E.J. Song, et al. 2000. Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cM interval on chromosome 15q. Am. J. Hum. Genet. 67 : 994 999.
64. Drivdal, M., T. Trydal, T.A. Hagve, et al. 2006. Prognosis, with evaluation of general biochemistry, of liver disease in lymphoedema cholestasis syndrome 1 (LCS1/Aagenaes syndrome). Scand. J. Gastroenterol. 41 : 465 471.
65. Witt, D.R., H.E. Hoyme, J. Zonana, et al. 1987. Lymphedema in Noonan syndrome: clues to pathogenesis and prenatal diagnosis and review of the literature. Am. J. Med. Genet. 27 : 841 856.
66. Mendez, H.M. & J.M. Opitz. 1985. Noonan syndrome: a review. Am. J. Med. Genet. 21 : 493 506.
67. Collins, E. & G. Turner. 1973. The Noonan syndrome: a review of the clinical and genetic features of 27 cases. J. Pediatr. 83 : 941 950.
68. Adams, F.H. & C.P. Oliver. 1945. Hereditary deformities in man due to arrest development. J. Hered. 36 : 3 8.
69. Pousti, T.J. & R.A. Bartlett. 1997. Adams-Oliver syndrome: genetics and associated anomalies of cutis aplasia. Plast. Reconstr. Surg. 100 : 1491 1496.
70. Koiffmann, C.P., A. Wajntal, B.J. Huyke, et al. 1988. Congenital scalp skull defects with distal limb anomalies (Adams-Oliver syndrome-McKusick 10030): further suggestion of autosomal recessive inheritance. Am. J. Med. Genet. 29 : 263 268.
71. Seizinger, B.R., G.A. Rouleau, L.J. Ozelius, et al. 1987. Linkage analysis in von Recklinghausen neurofibromatosis (NF1) with DNA markers for chromosome 17. Genomics 1 : 346 348.
72. Fountain, J.W., M.R. Wallace, A.M. Brereton, et al. 1989. Physical mapping of the von Recklinghausen neurofibromatosis region on chromosome 17. Am. J. Hum. Genet. 44 : 58 67.
73. Daston, M.M., H. Scrable, M. Nordlund, et al. 1992. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes. Neuron 8 : 415 428.
74. Brill, C.B. 1989. Neurofibromatosis. clinical overview. Clin. Orthop. Relat. Res. Aug 245 10 15.
75. Poussaint, T.Y., D. Jaramillo, Y. Chang, et al. 2003. Interobserver reproducibility of volumetric MR imaging measurements of plexiform neurofibromas. AJR Am. J. Roentgenol. 180 : 419 423.
76. Schajowicz, F., C.L. Aiello, M.V. Francone, et al. 1978. Cystic angiomatosis (hamartous haemolymphagiomatosis) of bone: a clinicopathological study of three cases. J. Bone Joint Surg. Br. 60 : 100 106.
77. Boyle, W.J. 1972. Cystic angiomatosis of bone: a report of three cases and review of the literature. J. Bone Joint Surg. Br. 54 : 626 636.
78. Levey, D.S., L.M. MacCormack, D.J. Sartoris, et al. 1996. Cystic angiomatosis: case report and review of the literature. Skeletal Radiol. 25 : 287 293.
79. Seckler, S.G., H. Rubin & J.G. Rabinowitz. 1964. Systemic cystic angiomatosis. Am. J. Med. 37 : 976 986.
80. Brunzell, J.D., S.W. Shankle & J.E. Bethune. 1968. Congenital generalized lipodystrophy accompanied by cystic angiomatosis. Ann. Intern. Med. 69 : 501 516.
81. Maffucci, A. 1881. Di un caso di encondroma ed angioma multiplo. Contribuzione alla genesi embrionale dei tumori. Movimento Medico-Chirurgico 3 : 399 412.
82. Kerr, H.D., J.C. Keep & S. Chiu. 1991. Lymphangiosarcoma associated with lymphedema in a man with Maffucci's syndrome. South Med. J. 84 : 1039 1041.
83. Jermann, M., K. Eid, T. Pfammatter, et al. 2001. Maffucci's syndrome. Circulation 104 : 1693.
84. Strang, C. & I. Rannie. 1950. Dyschondroplasia with haemangiomata (Maffucci's syndrome): report of a case complicated by intracranial chondrosarcoma. J. Bone Joint Surg. Br. 32-B : 376 383.
85. Kinmouth, J.B. 1982. The Lymphatics: Surgery, Lymphography and Diseases of the Chyle and Lymph Systems. Edward Arnold Publishers Ltd. London.
86. Holden, K.R. & F. Alexander. 1970. Diffuse neonatal hemangiomatosis. Pediatrics 46 : 411 421.
87. Lopriore, E. & D.G. Markhorst. 1999. Diffuse neonatal haemangiomatosis: new views on diagnostic criteria and prognosis. Acta. Paediatr. 88 : 93 97.
88. Lee, W.S., S.H. Kim, I. Kim, et al. 2002. Chylothorax in Gorham's disease. J. Korean Med. Sci. 17 : 826 829.
89. Patel, D.V. 2005. Gorham's disease or massive osteolysis. Clin. Med. Res. 3 : 65 74.
90. Remia, L.F., J. Richolt, K.M. Buckley, et al. 1998. Pain and weakness of the shoulder in a 16-year-old boy. Clin. Orthop. Relat. Res. Feb 347 268 271, 287 290.
91. Hejgaard, N. & P.R. Olsen. 1987. Massive Gorham osteolysis of the right hemipelvis complicated by chylothorax: report of a case in a 9-year-old boy successfully treated by pleurodesis. J. Pediatr. Orthop. 7 : 96 99.
92. Biesecker, L. 2006. The challenges of Proteus syndrome: diagnosis and management. Eur. J. Hum. Genet. 14 : 1151 1157.
93. Clark, R.D., D. Donnai, J. Rogers, et al. 1987. Proteus syndrome: an expanded phenotype. Am. J. Med. Genet. 27 : 99 117.
94. Kihiczak, G.G., J.G. Meine, R.A. Schwartz, et al. 2006. Klippel-Trenaunay syndrome: a multisystem disorder possibly resulting from a pathogenic gene for vascular and tissue overgrowth. Int. J. Dermatol. 45 : 883 890.
95. Mulliken, J.B. & J. Glowacki. 1982. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast. Reconstr. Surg. 69 : 412 422.
96. Tian, X.L., R. Kadaba, S.A. You, et al. 2004. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature 427 : 640 645.
97. Dubois, J., L. Garel, A. Grignon, et al. 1998. Imaging of hemangiomas and vascular malformations in children. Acad. Radiol. 5 : 390 400.
98. Dubois, J. & L. Garel. 1999. Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group. Pediatr. Radiol. 29 : 879 893.
99. Kern, S., C. Niemeyer, K. Darge, et al. 2000. Differentiation of vascular birthmarks by MR imaging: an investigation of hemangiomas, venous and lymphatic malformations. Acta. Radiol. 41 : 453 457.
100. Berry, S.A., C. Peterson, W. Mize, et al. 1998. Klippel-Trenaunay syndrome. Am. J. Med. Genet. 79 : 319 326.
101. Ring, D.S. & S.B. Mallory. 1992. What syndrome is this? Klippel-Trenaunay syndrome. Pediatr. Dermatol. 9 : 80 82.
102. Enjolras, O. & J.B. Mulliken. 1993. The current management of vascular birthmarks. Pediatr. Dermatol. 10 : 311 313.
103. Rodrigues, D., M.L.M. Bourrous, A.P.S. Ferrer, et al. 2000. Blue rubber bleb nevus syndrome. Rev. Hosp. Clin. Fac. Med. Sao Paulo 55 : 29 34.
104. Moodley, M. & P. Ramdial. 1993. Blue rubber bleb nevus syndrome: case report and review of the literature. Pediatrics 92 : 160 162.
105. Ertem, D., Y. Acar, E. Kotiloglu, et al. 2001. Blue rubber bleb nevus syndrome Pediatrics 107 : 418 420.
106. McCarthy, J.C., M.J. Goldberg & S. Zimbler. 1982. Orthopaedic dysfunction in the blue rubber-bleb nevus syndrome. J. Bone Joint Surg. Am. 64 : 280 283.
107. Chiu, N.T., B. Lee, S. Hwang, et al. 2001. Protein-losing enteropathy: diagnosis with (99m)Tc-labeled human serum albumin scintigraphy. Radiology 219 : 86 90.
108. Hilliard, R.I., J.B. McKendry & M.J. Phillips. 1990. Congenital abnormalities of the lymphatic system: a new clinical classification. Pediatrics 86 : 988 994.
109. Bhatnagar, A., R. Kashyap, U.P. Chauhan, et al. 1995. Diagnosing protein losing enteropathy: a new approach using Tc-99m human immunoglobulin. Clin. Nucl. Med. 20 : 969 972.
110. Strober, W., R.D. Wochner, P.P. Carbone, et al. 1967. Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. J. Clin. Invest. 46 : 1643 1656.
111. Donnelly, J.P., A. Rosenthal, V.P. Castle, et al. 1997. Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation. J. Pediatr. 130 : 474 478.
112. Warshaw, A.L., T.A. Waldmann & L. Laster. 1973. Protein-losing enteropathy and malabsorption in regional enteritis: cure by limited ileal resection. Ann. Surg. 178 : 578 580.
113. Rychik, J., D.A. Piccoli & G. Barber. 1991. Usefulness of corticosteroid therapy for protein-losing enteropathy after the Fontan procedure. Am. J. Cardiol. 68 : 819 821.
114. Rothman, A. & J. Snyder. 1991. Protein-losing enteropathy following the Fontan operation: resolution with prednisone therapy. Am. Heart J. 121 : 618 619.
115. Vardy, P.A., E. Lebenthal & H. Shwachman. 1975. Intestinal lymphagiectasia: a reappraisal. Pediatrics 55 : 842 851.
116. Fox, U. & G. Lucani. 1993. Disorders of the intestinal mesenteric lymphatic system. Lymphology 26 : 61 66.
117. Yang, D.M. & D.H. Jung. 2003. Localized intestinal lymphangiectasia: CT findings. AJR Am. J. Roentgenol. 180 : 213 214.
118. Holt, P.R. 1964. Dietary treatment of protein loss in intestinal lymphangiectasia: the effect of eliminating dietary long chain triglycerides on albumin metabolism in this condition. Pediatrics 34 : 629 635.
119. Fakhri, A., E.K. Fishman, B. Jones, et al. 1985. Primary intestinal lymphangiectasia: clinical and CT findings. J. Comput. Assist. Tomogr. 9 : 767 770.
120. Puri, A.S., R. Aggarwal, R.K. Gupta, et al. 1992. Intestinal lymphangiectasia: evaluation by CT and scintigraphy. Gastrointest. Radiol. 17 : 119 121.